Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PLTR

Palantir Technologies Inc

Mar 04 • 04:00PM ET

153.19

+5.97 4.06 %

Technology • Software - Infrastructure • USA • NASD

Mar 04, 4:50 PMPalantir reportedly rebuilding Pentagon Maven AI platform, replacing Anthropic’s Claude after Trump order barring military use of Anthropic

Peers: MSFT CRWD PANW SNOW DDOG ZS CRM ORCL ADBE TEAM

| Held by: VTI VOO QQQ IVV SPY VUG XLK VGT IWF QQQM

Index	NDX, S&P 500	P/E	242.08	EPS (ttm)	0.63	Insider Own	8.56%	Shs Outstand	2.29B	Perf Week	14.16%
Market Cap	366.38B	Forward P/E	82.78	EPS next Y	1.85	Insider Trans	-2.02%	Shs Float	2.19B	Perf Month	3.67%
Enterprise Value	359.53B	PEG	1.57	EPS next Q	0.28	Inst Own	56.12%	Short Float	2.35%	Perf Quarter	-8.54%
Income	1.63B	P/S	81.86	EPS this Y	72.05%	Inst Trans	1.71%	Short Ratio	1.09	Perf Half Y	-2.48%
Sales	4.48B	P/B	49.59	EPS next Y	43.42%	ROA	21.32%	Short Interest	51.37M	Perf YTD	-13.82%
Book/sh	3.09	P/C	51.03	EPS next 5Y	52.73%	ROE	26.23%	52W High	207.52 -26.18%	Perf Year	81.50%
Cash/sh	3.00	P/FCF	174.42	EPS past 3/5Y	- -	ROIC	21.46%	52W Low	66.12 131.68%	Perf 3Y	1739.02%
Dividend Est.	-	EV/EBITDA	249.65	Sales past 3/5Y	32.92% 32.58%	Gross Margin	82.37%	Volatility	4.51% 5.64%	Perf 5Y	519.45%
Dividend TTM	-	EV/Sales	80.33	EPS Y/Y TTM	232.56%	Oper. Margin	31.59%	ATR (14)	7.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.11	Sales Y/Y TTM	56.18%	Profit Margin	36.31%	RSI (14)	57.95	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.11	EPS Q/Q	658.01%	SMA20	12.02%	Beta	1.73	Target Price	187.90
Payout	0.00%	Debt/Eq	0.03	Sales Q/Q	70.00%	SMA50	-3.64%	Rel Volume	1.28	Prev Close	147.22
Employees	4429	LT Debt/Eq	0.02	Earnings	Feb 02 AMC	SMA200	-5.32%	Avg Volume	47.23M	Price	153.19
IPO	Sep 30, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.60% 4.90%	Trades		Volume	60,059,244	Change	4.06%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-27-26	Upgrade	UBS	Neutral → Buy	$150
Feb-27-26	Initiated	Rosenblatt	Buy	$150
Feb-18-26	Upgrade	Mizuho	Neutral → Outperform	$195
Feb-10-26	Upgrade	Daiwa Securities	Neutral → Buy	$180
Feb-03-26	Upgrade	Robert W. Baird	Neutral → Outperform	$200
Feb-03-26	Upgrade	Northland Capital	Market Perform → Outperform	$190
Feb-03-26	Upgrade	HSBC Securities	Hold → Buy	$205
Feb-02-26	Upgrade	William Blair	Mkt Perform → Outperform
Jan-12-26	Upgrade	Citigroup	Neutral → Buy	$235
Jan-06-26	Initiated	Truist	Buy	$223
Aug-05-25	Upgrade	Deutsche Bank	Sell → Hold	$160
Jul-25-25	Initiated	Piper Sandler	Overweight	$170
Jul-16-25	Upgrade	Mizuho	Underperform → Neutral	$135
Apr-01-25	Initiated	Daiwa Securities	Neutral	$90
Mar-05-25	Upgrade	William Blair	Underperform → Mkt Perform
Feb-20-25	Initiated	Loop Capital	Buy	$141
Feb-04-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$60 → $95
Jan-23-25	Reiterated	Wedbush	Outperform	$75 → $90
Jan-17-25	Initiated	Cantor Fitzgerald	Neutral	$72
Jan-06-25	Resumed	Morgan Stanley	Underweight	$60

Show Previous Ratings

Today 06:36AM	Palantir Stock Is Climbing -- Why U.S. Military AI Demand Is Driving the Rally (GuruFocus.com)
05:33AM	Anthropic's Dario Amodei Pushes To Salvage Pentagon Deal After Heated Negotiations: Report (Benzinga)
03:07AM	Gold.com and Autohome have been highlighted as Zacks Bull and Bear of the Day (Zacks)
12:03AM	Veteran analyst drops eye-popping price target on Palantir stock (TheStreet)
Mar-04-26 10:45PM	Palantir Faces Costly AI Overhaul After Trump Administration Bans Anthropic From Pentagon Work: Report (Benzinga)
04:37PM	Loading…
04:37PM	Palantir faces challenge to remove Anthropic from Pentagon's AI software (Reuters)
03:16PM	HubSpot and Other Software Stocks Are Bouncing Back. Their Next Move Could Come Soon. (Barrons.com)
03:05PM	Palantir vs. NVIDIA: Which AI Stock Offers the Better Valuation? (Zacks)
02:24PM	'AI Winner' HCA, Stock Of The Day, Gets Healthy With Palantir (Investor's Business Daily)
02:20PM	Stock Of The Day: Is This The Top For Palantir? (Benzinga)
01:56PM	Want to Invest in AI? Consider These 3 Bank Stocks. (Barchart)
01:40PM	SHLD Is Up 70.68% as AI and Drones Reshape Defense Investing (24/7 Wall St.)
11:30AM	Palantir Technologies (PLTR) Down 6.8% Since Last Earnings Report: Can It Rebound? (Zacks)
11:30AM	The Billionaire Investor Who Bet Against Nvidia and Palantir Is Buying Adobe (24/7 Wall St.)
11:00AM	Palantir Stock Technical Ratings Improve Amid Defense Sector Rally (Investor's Business Daily)
09:10AM	Loading…
09:10AM	BigBear.ai Revenues Slump in Q4: Temporary Dip or Deeper Issue? (Zacks)
07:30AM	1 Bold Expert Says Software Stocks Have Bottomed: 5 Top Names to Buy Now (Barchart)
06:10AM	Palantir Co-Founder Is Going To Dump $280 Million Worth Shares (GuruFocus.com)
05:30AM	Nvidia Swears Off an Earnings Crutch, Putting Pressure on Other Tech Companies (The Wall Street Journal)
Mar-03-26 04:39PM	Stocks Settle Lower on Iran War Anxiety (Barchart)
04:28PM	Stock Market Today: Dow Loses 400 Points Amid U.S.-Iran Battle; Palantir Climbs As Nvidia Slips (Live Coverage) (Investor's Business Daily)
04:07PM	Don't underestimate the role of Palantir, AI in Iran conflict (Yahoo Finance Video)
03:22PM	Stock Market Today: Dow Trims Losses Amid U.S.-Iran Fighting; Palantir Rises (Live Coverage) (Investor's Business Daily)
03:08PM	Pentagon dispute bolsters Anthropic reputation but raises questions about AI readiness in military (Associated Press Finance)
02:07PM	US strikes in Iran 'reinforce' a coming surge in defense spending. 3 key contractors are set to benefit. (Yahoo Finance)
01:51PM	SpaceX $1.75 Trillion IPO Valuation Deemed Justifiable by PitchBook (GuruFocus.com)
01:11PM	Why Palantir Is Back In Wall Street's Good Graces (Benzinga)
12:15PM	Analyst Praises Palantir's Growth Prospects, Sees Stock Headed To $400 Over Next 5 Years (Benzinga)
11:22AM	What's Going On With Penny Stock OneMedNet On Tuesday? (Benzinga)
11:06AM	EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In February - Where Do Tesla, Nvidia, Palantir Stocks Rank? (Benzinga)
10:34AM	Loading…
10:34AM	Palantir Stock Gets a New $200 Target -- Analyst Cites War Demand (GuruFocus.com)
09:54AM	Palantir's stock could surge almost 40% as Iran conflict dispels a big concern, analyst says (MarketWatch)
09:41AM	Palantir Is Back on Wall Streets Buy List After 38% Plunge (Bloomberg)
09:40AM	Cognizant Grows Through Expanding Clientele & Strong Partnerships (Zacks)
09:15AM	PLTR's Foundry and Gotham Accelerate Enterprise AI Expansion (Zacks)
08:42AM	Palantir Stock Drops. Its Role in the Iran Conflict Is Not a Given. (Barrons.com)
08:28AM	AI Stocks Hit Reset. CrowdStrike, Broadcom, Ciena Earnings Reports Due (Investor's Business Daily)
02:45AM	Peter Thiel Sells $290 Million In PLTR Stock As Palantir Surges Nearly 6% Amid AI-Driven Rally (Benzinga)
Mar-02-26 06:53PM	Stock market today: Dow, S&P 500, Nasdaq futures slide as Wall Street weighs Iran war impact (Yahoo Finance) +5.82%
06:48PM	Why Lockheed Martin & Palantir Technologies Should Be in Your Portfolio Right Now (Zacks)
06:30PM	US stocks end mixed, trading volatile amid Iran conflict (Reuters Videos)
05:05PM	These Stocks Are Todays Movers: AES, Norwegian, Elevance, Palantir, Lockheed, Strategy, Berkshire Hathaway, and More (Barrons.com)
04:47PM	Anthropic's Claude Joins Operation Epic Fury's Extensive Arms List (Investor's Business Daily)
04:37PM	Stock Market Today: Dow Dips As Trump Says This On Iran; Warren Buffett Stock Flashes Sell Signal (Live Coverage) (Investor's Business Daily)
04:32PM	US markets see-saw as investors keep close eye on Iran war (The Guardian)
04:07PM	Iran conflict bolsters defense sector outlook, says investor (Reuters Videos)
04:04PM	Lockheed Martin, RTX Corp Stocks Hit All-Time Highs On Iran Attack: Here's The Congress Members Who Own Shares (Benzinga)
03:29PM	Palantir Shares Rise as Analysts See Pentagon Ties Intact (GuruFocus.com)
03:12PM	Stock Market Today: Dow Up As Trump Says This On Iran; This Oil Stock Clears Entry As Prices Pop (Live Coverage) (Investor's Business Daily)
03:12PM	Palantir Rises on Mideast Conflict. Why Its Moving Like a Defense Stock. (Barrons.com)
02:56PM	Why Palantir Stock Is Climbing Today (GuruFocus.com)
02:53PM	Palantir's War-Led Bounce Could Be Just The Start For These ETFs (Benzinga)
02:44PM	Use This Zacks Tool to Find AI Stocks Like NVIDIA and Palantir (Zacks)
01:52PM	Retail investors are piling into energy ETFs on Monday: Vanda Research (MarketWatch)
01:45PM	One Source of Strength in the Markets Today: Tech Stocks (The Wall Street Journal)
01:37PM	Palantir Rallies as Iran War Ramps Up (Moby)
01:29PM	Stock Market Today: Dow Lags As Trump Says This On Iran; LNG Stock Clears Entry As Oil Prices Pop (Live Coverage) (Investor's Business Daily)
01:21PM	Former NATO commander on how Operation Epic Fury shows the role of AI (Yahoo Finance)
01:19PM	Palantir, Energy Stocks Rally, Cruise Lines Tumble On US And Israeli-Iran War: What's Moving Markets Monday? (Benzinga)
12:43PM	Stock Market Today: Nasdaq Up After U.S.-Iran Attacks; LNG Stock Clears Entry As Oil Prices Pop (Live Coverage) (Investor's Business Daily)
12:26PM	Palantir lifts the technology sector, but other AI stocks remain under pressure (MarketWatch)
12:25PM	Palantir Technologies (PLTR) Shares Skyrocket, What You Need To Know (StockStory)
11:58AM	Oil Stocks Heat Up Amid Iran War As S&P 500 Slips; How High Will Oil Prices Go? (Investor's Business Daily)
11:13AM	Nasdaq turns positive as Wall Street reacts to Iran war (Proactive)
11:10AM	Could Palantir Technologies Accidentally Kill Its Golden AI Goose? (24/7 Wall St.)
10:51AM	Palantir Joins Rally In Defense Stocks Amid U.S.-Iran War (Investor's Business Daily)
10:47AM	Energy stocks rise on oil prices, BlackRock consortium to acquire AES (Yahoo Finance Video)
09:32AM	Palantir's War Trade Is Back - But Beware The 'Death Cross' (Benzinga)
09:30AM	Wall Street Bulls Look Optimistic About Palantir Technologies (PLTR): Should You Buy? (Zacks)
09:19AM	Palantir, Lockheed and these other defense stocks are rising on heels of Iran conflict (MarketWatch)
09:13AM	Palantir Rises as Other AI Stocks Fall. Those Defense Contracts Are Paying Off. (Barrons.com)
09:00AM	Palantir Technologies Inc. (PLTR) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
09:00AM	AI is blowing up one of shadow bankings biggest bets (The Telegraph)
07:46AM	AI Stocks Hit Reset. Why Optical Plays Are Hot. Citrini Ignites Doomsday Flap. (Investor's Business Daily)
07:04AM	Palantir Stock Gets Fresh "Buy" Call -- $150 Target Ignites AI Debate (GuruFocus.com)
06:20AM	Bear of the Day: AST SpaceMobile (ASTS) (Zacks)
01:31AM	Michael Burry Says Dropping Claude Was A 'Trumpian' Thing To Do But Pentagon's Six-Month Phase Shows 'Stickiness' Of Anthropic's Tech (Benzinga)
Mar-01-26 01:02PM	Anthropics Battle With President Trump Over AI Weapons Needs to Be Resolved Quickly (Barrons.com)
Feb-28-26 09:51PM	UBS Sees Palantir (PLTR) Positioned at Center of AI and Software Spending Boom (Insider Monkey)
07:04PM	Jim Cramer Believes "Palantir Is a Very Long-Term Hold" (Insider Monkey)
12:20PM	Anthropic Responds to President Trump in the Battle Over AI Weapons. (Barrons.com)
08:01AM	Netflix, Nvidia, AMD And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week (Benzinga)
02:07AM	EMCOR Group Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 07:09PM	Trump Bars Anthropic From Federal Agencies and Hegseth Labels It a Supply Chain Risk. Here's Why. (Barrons.com) +5.82%
03:37PM	Palantir's stock nabs another upgrade, with its valuation now less of a 'struggle' (MarketWatch)
01:06PM	Palantir Stock Gets an Upgrade. Analysts and Customers See Growth Opportunities. (Barrons.com)
12:22PM	Rackspace Tumbles as Business Improves, but Is It a Buy Yet? (24/7 Wall St.)
12:18PM	Palantir upgraded to Buy by UBS on strong AI and data demand (Proactive)
10:45AM	OneMedNet Stock Skyrockets As It Rolls Out Next RWD Phase With Palantir Foundry (Benzinga)
09:50AM	Block upgraded, Duolingo downgraded: Wall Street's top analyst calls (The Fly)
07:59AM	Here Are Fridays Top Wall Street Analyst Research Calls: Block, Costco, Dollar Tree, Duolingo, Palantir Technologies, Southwest Airlines, Synopsis, Warner Bros. Discovery, and More (24/7 Wall St.)
07:42AM	UBS raises Palantir to Buy as shares become very attractive after pullback (Investing.com)
07:28AM	Palantir Stock Drops 20% as Valuation Concerns Mount -- Analysts See Buying Opportunity (GuruFocus.com)
06:22AM	Palantir Technologies Upgraded by UBS Following 35% Pullback (GuruFocus.com)
05:45AM	Rackspace Technology Q4 Earnings Call Highlights (MarketBeat)
05:23AM	Nvidia Looks Like a Value Stock Even as Earnings Scream Growth (Bloomberg)
Feb-26-26 11:14PM	Innodata Q4 Earnings Call Highlights (MarketBeat)
08:04PM	3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR (Zacks)
12:30PM	Palantir vs. Zeta: Which AI-Driven Data Stock is the Better Buy? (Zacks)
09:50AM	Zacks.com featured highlights include Palantir Technologies, Brinker International and Carpenter Technology (Zacks)

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
THIEL PETER	Director	Mar 02 '26	Sale	144.85	2,000,000	289,707,507	13,733,625	Mar 04 04:28 PM
Peter Thiel	Officer	Mar 02 '26	Proposed Sale	140.00	2,000,000	280,000,000		Mar 02 08:41 PM
Buckley Jeffrey	See Remarks	Feb 20 '26	Sale	133.72	2,704	361,575	44,340	Feb 24 08:12 PM
Buckley Jeffrey	See Remarks	Feb 24 '26	Sale	129.08	1,232	159,027	43,108	Feb 24 08:12 PM
Taylor Ryan D.	See Remarks	Feb 20 '26	Sale	133.72	19,988	2,672,765	219,421	Feb 24 08:12 PM
Glazer David A.	See Remarks	Feb 20 '26	Sale	133.72	17,438	2,331,782	392,370	Feb 24 08:11 PM
Sankar Shyam	See Remarks	Feb 20 '26	Sale	133.72	168,004	22,465,231	642,786	Feb 24 08:10 PM
Cohen Stephen Andrew	See Remarks	Feb 20 '26	Sale	133.72	327,088	43,737,696	592	Feb 24 08:09 PM
Karp Alexander C.	See Remarks	Feb 20 '26	Sale	133.78	493,025	65,955,988	6,432,258	Feb 24 08:08 PM
RYAN TAYLOR	Officer	Feb 20 '26	Proposed Sale	133.72	19,988	2,672,763		Feb 20 05:35 PM
STEPHEN A COHEN	Officer	Feb 20 '26	Proposed Sale	133.72	327,088	43,737,684		Feb 20 05:25 PM
SHYAM SANKAR	Officer	Feb 20 '26	Proposed Sale	133.72	168,004	22,465,226		Feb 20 05:01 PM
ALEXANDER KARP	Officer	Feb 20 '26	Proposed Sale	133.72	403,025	53,891,858		Feb 20 04:56 PM
DAVID GLAZER	Officer	Feb 20 '26	Proposed Sale	133.72	17,438	2,331,781		Feb 20 04:47 PM
ALEXANDER KARP	Director	Feb 20 '26	Proposed Sale	134.89	90,000	12,140,100		Feb 20 04:27 PM
Stat Lauren Elaina Friedman	Director	Feb 02 '26	Sale	151.14	400	60,456	58,287	Feb 04 08:25 PM
Moore Alexander D.	Director	Feb 02 '26	Sale	149.65	20,000	2,992,984	1,172,978	Feb 04 08:19 PM
LAUREN STAT	Director	Feb 02 '26	Proposed Sale	146.59	400	58,636		Feb 02 04:31 PM
Stat Lauren Elaina Friedman	Director	Jan 02 '26	Sale	181.35	3,400	616,590	58,687	Jan 06 08:21 PM
Moore Alexander D.	Director	Jan 02 '26	Sale	172.98	20,000	3,459,615	1,192,978	Jan 06 08:08 PM
Taylor Ryan D.	See Remarks	Jan 02 '26	Sale	181.35	12,000	2,176,200	239,409	Jan 06 08:07 PM
RYAN DOUGLAS TAYLOR	Officer	Jan 02 '26	Proposed Sale	177.75	12,000	2,133,000		Jan 02 04:33 PM
LAUREN STAT	Director	Jan 02 '26	Proposed Sale	177.75	3,400	604,350		Jan 02 04:30 PM
Alexander D. Moore	Director	Jan 02 '26	Proposed Sale	177.75	40,000	7,110,000		Jan 02 04:12 PM
Glazer David A.	See Remarks	Dec 12 '25	Option Exercise	4.72	9,000	42,480	422,639	Dec 16 08:16 PM
Glazer David A.	See Remarks	Dec 12 '25	Sale	185.91	9,000	1,673,190	413,639	Dec 16 08:16 PM
DAVID A. GLAZER	Officer	Dec 12 '25	Proposed Sale	187.54	9,000	1,687,860		Dec 12 04:27 PM
Moore Alexander D.	Director	Dec 01 '25	Sale	167.19	20,000	3,343,833	1,212,978	Dec 03 08:02 PM
Buckley Jeffrey	See Remarks	Nov 20 '25	Sale	163.99	2,365	387,833	48,596	Nov 24 08:17 PM
Buckley Jeffrey	See Remarks	Nov 24 '25	Sale	157.50	1,252	197,190	47,044	Nov 24 08:17 PM
Buckley Jeffrey	See Remarks	Nov 21 '25	Sale	156.25	300	46,875	48,296	Nov 24 08:17 PM
Taylor Ryan D.	See Remarks	Nov 24 '25	Sale	162.36	36,048	5,852,784	251,409	Nov 24 08:16 PM
Taylor Ryan D.	See Remarks	Nov 20 '25	Sale	163.99	17,761	2,912,566	289,709	Nov 24 08:16 PM
Taylor Ryan D.	See Remarks	Nov 21 '25	Sale	156.25	2,252	351,878	287,457	Nov 24 08:16 PM
Glazer David A.	See Remarks	Nov 20 '25	Sale	163.99	15,557	2,551,122	415,612	Nov 24 08:14 PM
Glazer David A.	See Remarks	Nov 21 '25	Sale	156.25	1,973	308,286	413,639	Nov 24 08:14 PM
Sankar Shyam	See Remarks	Nov 20 '25	Sale	163.99	149,872	24,576,902	642,786	Nov 24 08:13 PM
Sankar Shyam	See Remarks	Nov 21 '25	Sale	156.25	19,004	2,969,402	642,786	Nov 24 08:13 PM
Cohen Stephen Andrew	See Remarks	Nov 20 '25	Sale	163.99	308,635	50,611,809	592	Nov 24 08:12 PM
Cohen Stephen Andrew	See Remarks	Nov 21 '25	Sale	156.25	39,136	6,115,055	592	Nov 24 08:12 PM
Karp Alexander C.	See Remarks	Nov 20 '25	Sale	163.99	359,325	58,924,266	6,432,258	Nov 24 08:09 PM
Karp Alexander C.	See Remarks	Nov 21 '25	Sale	156.25	45,564	7,119,436	6,432,258	Nov 24 08:09 PM
RYAN D. TAYLOR	Officer	Nov 24 '25	Proposed Sale	154.85	36,048	5,582,033		Nov 24 04:31 PM
STEPHEN COHEN	Officer	Nov 20 '25	Proposed Sale	163.99	405,000	66,414,330		Nov 20 06:22 PM
RYAN TAYLOR	Officer	Nov 20 '25	Proposed Sale	163.99	23,290	3,819,234		Nov 20 06:07 PM
DAVID GLAZER	Officer	Nov 20 '25	Proposed Sale	163.99	23,290	3,819,234		Nov 20 06:03 PM
SHYAM SANKAR	Officer	Nov 20 '25	Proposed Sale	163.99	225,000	36,896,850		Nov 20 05:45 PM
ALEXANDER KARP	Officer	Nov 20 '25	Proposed Sale	163.99	585,000	95,931,810		Nov 20 05:29 PM
Moore Alexander D.	Director	Nov 03 '25	Sale	204.54	20,000	4,090,887	1,232,978	Nov 05 08:01 PM
Stat Lauren Elaina Friedman	Director	Oct 03 '25	Sale	186.39	800	149,112	62,087	Oct 07 08:02 PM
Moore Alexander D.	Director	Oct 01 '25	Sale	184.01	20,000	3,680,225	1,252,978	Oct 03 08:03 PM
LAUREN STAT	Director	Oct 03 '25	Proposed Sale	187.05	800	149,640		Oct 03 04:30 PM
Alexander D. Moore	Director	Oct 01 '25	Proposed Sale	182.42	60,000	10,945,200		Oct 01 04:07 PM
Stat Lauren Elaina Friedman	Director	Sep 18 '25	Sale	177.60	9,000	1,598,400	50,794	Sep 22 08:07 PM
DAVID STAT	Director	Sep 18 '25	Proposed Sale	168.33	9,000	1,514,970		Sep 18 04:33 PM
Stat Lauren Elaina Friedman	Director	Sep 11 '25	Sale	165.95	21,000	3,484,866	59,794	Sep 15 07:59 PM
DAVID STAT	Director	Sep 11 '25	Proposed Sale	166.74	21,000	3,501,540		Sep 11 04:24 PM
Taylor Ryan D.	See Remarks	Sep 05 '25	Sale	158.35	36,048	5,708,057	307,470	Sep 09 08:26 PM
RYAN D. TAYLOR	Officer	Sep 05 '25	Proposed Sale	156.14	36,048	5,628,535		Sep 05 04:24 PM
Moore Alexander D.	Director	Sep 02 '25	Sale	156.42	20,000	3,128,318	1,272,978	Sep 04 08:09 PM
Glazer David A.	See Remarks	Sep 02 '25	Option Exercise	4.72	37,770	178,274	512,169	Sep 04 08:08 PM
Glazer David A.	See Remarks	Sep 02 '25	Sale	154.47	81,000	12,511,782	431,169	Sep 04 08:08 PM
Buckley Jeffrey	See Remarks	Aug 29 '25	Sale	157.00	2,803	440,071	50,961	Sep 03 08:03 PM
DAVID GLAZER	Officer	Sep 02 '25	Proposed Sale	156.71	81,000	12,693,510		Sep 02 04:52 PM
Buckley Jeffrey	See Remarks	Aug 20 '25	Sale	151.36	1,289	195,108	54,840	Aug 22 07:59 PM
Buckley Jeffrey	See Remarks	Aug 21 '25	Sale	155.75	1,076	167,592	53,764	Aug 22 07:59 PM
Taylor Ryan D.	See Remarks	Aug 20 '25	Sale	151.37	11,026	1,668,970	352,729	Aug 22 07:59 PM
Taylor Ryan D.	See Remarks	Aug 21 '25	Sale	155.75	9,211	1,434,648	343,518	Aug 22 07:59 PM
Glazer David A.	See Remarks	Aug 20 '25	Sale	151.37	9,633	1,458,115	482,446	Aug 22 07:58 PM
Glazer David A.	See Remarks	Aug 21 '25	Sale	155.75	8,047	1,253,350	474,399	Aug 22 07:58 PM
Sankar Shyam	See Remarks	Aug 20 '25	Sale	151.37	93,092	14,090,976	702,786	Aug 22 07:58 PM
Sankar Shyam	See Remarks	Aug 21 '25	Sale	155.75	77,769	12,112,815	702,786	Aug 22 07:58 PM
Sankar Shyam	See Remarks	Aug 22 '25	Sale	159.55	30,000	4,786,457	702,786	Aug 22 07:58 PM
Sankar Shyam	See Remarks	Aug 20 '25	Sale	151.20	375,000	56,699,646	702,786	Aug 22 07:55 PM
Cohen Stephen Andrew	See Remarks	Aug 20 '25	Sale	151.37	191,720	29,019,923	592	Aug 22 07:54 PM
Cohen Stephen Andrew	See Remarks	Aug 21 '25	Sale	155.75	160,164	24,946,145	592	Aug 22 07:54 PM
Karp Alexander C.	See Remarks	Aug 20 '25	Sale	151.37	222,878	33,736,205	6,432,258	Aug 22 07:53 PM
Karp Alexander C.	See Remarks	Aug 21 '25	Sale	155.75	186,194	29,000,415	6,432,258	Aug 22 07:53 PM
Sankar Shyam	Officer	Aug 22 '25	Proposed Sale	155.31	30,000	4,659,450		Aug 22 04:11 PM
SHYAM SANKAR	Officer	Aug 20 '25	Proposed Sale	151.37	225,000	34,057,395		Aug 20 06:38 PM
RYAN TAYLOR	Officer	Aug 20 '25	Proposed Sale	151.37	23,290	3,525,319		Aug 20 06:14 PM
ALEXANDER C. KARP	Officer	Aug 20 '25	Proposed Sale	151.37	585,000	88,549,227		Aug 20 06:08 PM
DAVID GLAZER	Officer	Aug 20 '25	Proposed Sale	151.37	23,290	3,525,319		Aug 20 06:04 PM
STEPHEN A COHEN	Officer	Aug 20 '25	Proposed Sale	151.37	405,000	61,303,311		Aug 20 05:23 PM
Sankar Shyam	Officer	Aug 20 '25	Proposed Sale	152.30	375,000	57,112,500		Aug 20 04:20 PM
Taylor Ryan D.	See Remarks	Aug 05 '25	Sale	175.00	30,000	5,250,000	363,755	Aug 07 08:05 PM
Moore Alexander D.	Director	Aug 01 '25	Sale	154.73	20,000	3,094,523	1,292,978	Aug 05 08:05 PM
RYAN D. TAYLOR	Officer	Aug 05 '25	Proposed Sale	160.66	30,000	4,819,800		Aug 05 04:27 PM
Taylor Ryan D.	See Remarks	Jul 15 '25	Option Exercise	4.72	33,335	157,341	397,090	Jul 17 08:02 PM
Taylor Ryan D.	See Remarks	Jul 15 '25	Sale	150.00	33,335	5,000,250	363,755	Jul 17 08:02 PM
RYAN D. TAYLOR	Officer	Jul 15 '25	Proposed Sale	149.15	33,335	4,971,915		Jul 15 04:19 PM
Stat Lauren Elaina Friedman	Director	Jul 09 '25	Sale	139.61	800	111,688	62,887	Jul 11 08:05 PM
LAUREN STAT	Director	Jul 09 '25	Proposed Sale	139.71	800	111,768		Jul 09 04:14 PM
Woersching Eric H.	Director	Jul 01 '25	Sale	130.95	10,214	1,337,545	2,348	Jul 03 04:23 PM
Moore Alexander D.	Director	Jul 01 '25	Sale	131.06	20,000	2,621,113	1,312,978	Jul 03 04:21 PM
Taylor Ryan D.	See Remarks	Jul 01 '25	Option Exercise	4.72	33,335	157,341	397,090	Jul 03 04:20 PM
Taylor Ryan D.	See Remarks	Jul 01 '25	Sale	135.31	33,335	4,510,452	363,755	Jul 03 04:20 PM
ERIC WOERSCHING	Director	Jul 01 '25	Proposed Sale	136.32	10,214	1,392,372		Jul 01 04:34 PM
RYAN DOUGLAS TAYLOR	Officer	Jul 01 '25	Proposed Sale	136.32	33,335	4,544,227		Jul 01 04:32 PM
Palantir Technologies Inc.	10% Owner	Jun 18 '25	Buy	2.07	1,040,557	2,153,953	4,461,564	Jun 23 09:19 PM

Open in Screener

ABCL

AbCellera Biologics Inc

Mar 04 • 04:00PM ET

3.63

-0.08 -2.16 %

Healthcare • Biotechnology • Canada • NASD

ABCL AbCellera Biologics Inc daily Stock Chart

Peers: REGN AMGN VRTX MRNA BNTX INCY ALNY NVAX IONS EXEL

| Held by: IBB SPDW IDNA GWX ONEQ BBC AVUS PDN AVSC IBBQ

Index	-	P/E	-	EPS (ttm)	-0.49	Insider Own	23.33%	Shs Outstand	300.60M	Perf Week	13.79%
Market Cap	1.10B	Forward P/E	-	EPS next Y	-0.66	Insider Trans	0.00%	Shs Float	232.44M	Perf Month	3.71%
Enterprise Value	683.36M	PEG	-	EPS next Q	-0.16	Inst Own	36.55%	Short Float	21.60%	Perf Quarter	4.61%
Income	-146.41M	P/S	14.65	EPS this Y	-31.97%	Inst Trans	2.14%	Short Ratio	11.93	Perf Half Y	-10.37%
Sales	75.13M	P/B	1.13	EPS next Y	-1.75%	ROA	-10.78%	Short Interest	50.22M	Perf YTD	6.14%
Book/sh	3.22	P/C	1.96	EPS next 5Y	-16.76%	ROE	-14.47%	52W High	6.51 -44.28%	Perf Year	55.13%
Cash/sh	1.85	P/FCF	-	EPS past 3/5Y	- -	ROIC	-13.26%	52W Low	1.89 92.00%	Perf 3Y	-56.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-46.31% -20.27%	Gross Margin	61.64%	Volatility	8.92% 7.80%	Perf 5Y	-87.92%
Dividend TTM	-	EV/Sales	9.10	EPS Y/Y TTM	11.33%	Oper. Margin	-288.98%	ATR (14)	0.26	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.23	Sales Y/Y TTM	160.55%	Profit Margin	-194.89%	RSI (14)	54.33	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	11.32	EPS Q/Q	74.24%	SMA20	11.49%	Beta	0.86	Target Price	9.20
Payout	-	Debt/Eq	0.15	Sales Q/Q	788.18%	SMA50	-0.47%	Rel Volume	0.75	Prev Close	3.71
Employees	562	LT Debt/Eq	0.14	Earnings	Feb 24 AMC	SMA200	-9.61%	Avg Volume	4.21M	Price	3.63
IPO	Dec 11, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	77.61% 572.89%	Trades		Volume	3,180,057	Change	-2.16%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$4
Jul-07-25	Resumed	Leerink Partners	Outperform	$5
Aug-20-24	Downgrade	The Benchmark Company	Buy → Hold
Feb-22-24	Upgrade	The Benchmark Company	Hold → Buy	$9
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$6
Nov-06-23	Downgrade	The Benchmark Company	Buy → Hold
Oct-13-23	Resumed	Piper Sandler	Overweight	$20
Feb-28-23	Initiated	Cowen	Outperform
Dec-15-22	Initiated	Goldman	Buy	$30
Nov-16-22	Initiated	Truist	Buy	$29
Dec-21-21	Initiated	The Benchmark Company	Buy	$27
Nov-19-21	Initiated	Piper Sandler	Overweight	$33
Jan-05-21	Initiated	SVB Leerink	Outperform	$45
Jan-05-21	Initiated	Stifel	Buy	$59
Jan-05-21	Initiated	Credit Suisse	Outperform	$52
Jan-05-21	Initiated	BMO Capital Markets	Outperform	$48
Jan-05-21	Initiated	Berenberg	Buy	$53

Show Previous Ratings

Mar-04-26 11:50AM	AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says (MarketBeat)
Feb-26-26 02:28PM	AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M (Insider Monkey) +12.54%
Feb-25-26 08:02PM	AbCellera Biologics Inc. Q4 2025 Earnings Call Summary (Moby)
03:51AM	What Sparked AbCellera Biologics To Soar Over 9% After Hours (Benzinga)
12:00AM	AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
09:55PM	Loading…
Feb-24-26 09:55PM	AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +6.27%
06:26PM	AbCellera Biologics Q4 Earnings Call Highlights (MarketBeat)
04:05PM	AbCellera Reports Full Year 2025 Business Results (Business Wire)
Feb-19-26 07:30AM	3 New Stocks SoftBank Is Betting Big on in 2026 (Barchart)
Feb-18-26 09:43AM	SoftBank Adds TwentyOne Capital, Exits Nvidia in Q4 Portfolio Shift (GuruFocus.com)
Feb-11-26 04:05PM	AbCellera to Present at Upcoming Investor Conferences in March and April 2026 (Business Wire) -6.07%
Feb-02-26 07:49PM	AbCellera Biologics Inc. (ABCL): A Bull Case Theory (Insider Monkey)
Jan-29-26 01:49PM	What Does Wall Street Think About AbCellera Biologics Inc. (ABCL)? (Insider Monkey)
Jan-22-26 04:05PM	AbCellera to Report Full Year 2025 Financial Results on February 24, 2026 (Business Wire) +8.41% -8.62%
Jan-14-26 08:07PM	AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 (MarketBeat)
09:00AM	Loading…
Jan-12-26 09:00AM	AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause (Business Wire)
Dec-08-25 04:05PM	AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 (Business Wire)
Dec-04-25 10:09PM	AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results (Insider Monkey)
Nov-25-25 08:16AM	AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss (Insider Monkey)
Nov-18-25 06:17AM	Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? (Insider Monkey)
Nov-07-25 12:12AM	AbCellera Biologics Inc (ABCL) Q3 2025 Earnings Call Highlights: Transition to Clinical-Stage ... (GuruFocus.com) -13.69%
Nov-06-25 05:45PM	AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q3 2025 Business Results (Business Wire)
Oct-21-25 10:47PM	AbCellera Biologics Inc. (ABCL): A Bull Case Theory (Insider Monkey)
Oct-07-25 04:05PM	AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 (Business Wire) +6.93%
Sep-30-25 09:40AM	Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year? (Zacks)
Sep-29-25 04:05PM	AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025 (Business Wire)
12:00PM	AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy? (Zacks)
Sep-21-25 09:26AM	New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)'s Push Into Immunology and Beyond (Insider Monkey)
Sep-20-25 02:43AM	AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer (Insider Monkey)
08:17AM	Loading…
Sep-15-25 08:17AM	TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575 (Insider Monkey)
Sep-10-25 09:07AM	AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer (Business Wire)
Aug-28-25 05:04AM	AbCellera Biologics Inc. (ABCL) Launches First Human Trial for Menopause Therapy (Insider Monkey)
Aug-27-25 09:00AM	AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575 (Business Wire)
Aug-25-25 11:56PM	Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PT (Insider Monkey)
Aug-17-25 06:10PM	AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial Results (Insider Monkey)
Aug-12-25 04:05PM	AbCellera to Participate at Upcoming Investor Conferences in September (Business Wire) -5.11% +7.26%
Aug-08-25 03:42AM	AbCellera Biologics Inc (ABCL) Q2 2025 Earnings Call Highlights: Revenue Surge and Clinical ... (GuruFocus.com)
Aug-07-25 06:20PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms (Business Wire)
Aug-05-25 05:55PM	Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates (Zacks) -5.50%
Jul-31-25 10:00AM	AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jul-24-25 10:06AM	AbCellera Biologics Inc. (ABCL): A Bull Case Theory (Insider Monkey)
Jul-22-25 11:03AM	Leerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following Pivot (Insider Monkey)
09:39AM	Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength? (Zacks)
Jul-07-25 04:05PM	AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire) +6.05%
09:11AM	Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating (Insider Monkey)
Jun-25-25 04:09AM	AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology (Insider Monkey)
Jun-09-25 09:13AM	AbCellera Biologics Inc. (ABCL): A Bull Case Theory (Insider Monkey)
Jun-03-25 12:00PM	ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why (Zacks) +7.94%
Jun-02-25 06:45PM	Why AbCellera Biologics Stock Raced Nearly 6% Higher Today (Motley Fool) +5.94%
May-30-25 01:00PM	AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575 (Business Wire)
May-21-25 11:21AM	AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential (Insider Monkey)
May-14-25 05:00PM	AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause (Business Wire)
May-12-25 03:30PM	AbCelleras Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit (Business Wire)
May-09-25 07:30PM	AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting (Business Wire)
11:22AM	Q1 2025 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
03:50AM	AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-25 06:05PM	AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q1 2025 Business Results (Business Wire)
May-07-25 12:39PM	AbCellera Biologics Q1 2025 Earnings Preview (Seeking Alpha)
10:45AM	AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-29-25 03:00PM	AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025 (Business Wire)
Apr-23-25 10:14AM	Is AbCellera Biologics Inc. (ABCL) the Best Canadian Penny Stock to Invest in Now? (Insider Monkey)
Apr-16-25 11:59PM	AbCellera: Attractively Priced But A Catalyst Is Needed (Seeking Alpha)
Apr-08-25 04:05PM	AbCellera to Participate at Upcoming Investor Conferences in May and June (Business Wire) -5.85% +12.44%
Apr-03-25 04:05PM	AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025 (Business Wire) -5.86%
Mar-25-25 04:30PM	AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025 (Business Wire)
Feb-28-25 02:18PM	Q4 2024 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -11.47%
02:43AM	AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ... (GuruFocus.com)
Feb-27-25 10:15PM	AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript (Motley Fool)
06:15PM	AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Full Year 2024 Business Results (Business Wire)
Feb-26-25 07:55AM	What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earnings (GuruFocus.com)
Feb-11-25 04:05PM	AbCellera to Participate at Upcoming Investor Conferences in March (Business Wire) +5.08%
Jan-21-25 04:05PM	AbCellera to Report Full Year 2024 Financial Results on February 27, 2025 (Business Wire) +15.36%
Jan-17-25 07:53AM	AbCellera Biologics Inc. (ABCL): A Bull Case Theory (Insider Monkey)
Jan-15-25 10:47AM	AbbVie and Simcere Zaiming link to develop trispecific antibody (Pharmaceutical Technology) +6.86%
Jan-14-25 09:25AM	AbCellera expands collaboration with AbbVie (TipRanks) -7.67%
Jan-13-25 09:00AM	AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology (Business Wire)
Jan-07-25 09:11AM	Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy According to Analysts? (Insider Monkey)
Nov-21-24 04:05PM	AbCellera to Present at Upcoming Investor Conferences in December and January (Business Wire)
Nov-07-24 10:05AM	AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 (Business Wire)
Nov-05-24 11:17AM	Q3 2024 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -5.88%
02:11AM	AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Nov-04-24 11:00PM	AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript (Motley Fool) +5.86%
05:55PM	AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q3 2024 Business Results (Business Wire)
Nov-01-24 09:06AM	AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-22-24 04:05PM	AbCellera to Present at Upcoming Investor Conferences in November 2024 (Business Wire)
Oct-16-24 08:58AM	Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts? (Insider Monkey)
Oct-04-24 09:00AM	AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 (Business Wire)
Sep-26-24 04:05PM	AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 (Business Wire)
Sep-01-24 10:26PM	AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025? (Insider Monkey)
Aug-29-24 08:41PM	10 Best Multibagger Penny Stocks of 2025 (Insider Monkey)
04:05PM	AbCellera to Present at Upcoming Investor Conferences in September (Business Wire)
05:13AM	AbCellera Biologics Inc. (ABCL): A Top Contender Among Canadas Best Penny Stocks in 2024 (Insider Monkey)
Aug-07-24 12:45AM	AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript (Motley Fool) -7.72%
Aug-06-24 06:15PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q2 2024 Business Results (Business Wire)

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

FB ProShares S&P 500 Dynamic Buffer ETF daily Stock Chart

Category	US Equities - Quant Strat	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	-	Total Holdings	504	Perf Week	-0.18%
Sponsor	ProShares	ETF Type		Tags	options	Return% 3Y	-	AUM	1.70M	Perf Month	0.81%
Fund Family		Bond Type		Tags	SP500	Return% 5Y	-	NAV/sh		Perf Quarter	0.85%
Index	S&P 500 Daily Dynamic Buffer Index	Average Maturity		Tags	buffer	Return% 10Y		52W High	42.69 -0.20%	Perf Half Y	4.06%
Index Weighting		Commodity Type		Tags	upside-cap	Return% SI		52W Low	39.91 6.75%	Perf YTD	0.96%
Active/Passive		Quant Type		Tags	-	Flows% 1M	0.00%	Volatility	0.33% 0.16%	Perf Year	-
Dividend TTM	0.39 (0.91%)	ESG Type		Tags	-	Flows% 3M	-19.87%	ATR (14)	0.13	Perf 3Y	-
Dividend Ex-Date	Dec 24, 2025	Dividend Type		Sector/Theme		Flows% YTD	0.00%	RSI (14)	58.26	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	-	Perf 10Y	-
Expense	0.58%	Growth/Value		SMA20	0.39%	Flows% 3Y		Rel Volume	0.23	Prev Close	42.52
Inverse/Leveraged		Market Cap		SMA50	0.51%	Flows% 5Y		Avg Volume	0.72K	Price	42.60
IPO	Jun 26, 2025	Option/Short	No / Yes	SMA200	2.50%	Trades		Volume	163	Change	0.20%

Feb-11-26 06:50AM	Trump Administration Seeks Public Pledge From Tech Firms To Limit Data Center Strain On Utilities: Report (Benzinga)
Dec-16-25 02:39PM	These Are The 5 Best Stocks To Buy Now Or Watch (Investor's Business Daily)
Dec-09-25 04:24PM	Half of companies don't think women's career advancement is a priority: Facebook's Sheryl Sandberg (CNBC TV)
Dec-07-25 03:10PM	Executive Exodus Hits Apple As Fears Grow Over Possible Chip Chief Departure (Benzinga)
Nov-24-25 07:30PM	Hyperscalers Crash the Grid as Big Tech Becomes a Power Trader (Oilprice.com)
09:33AM	Loading…
Nov-11-25 09:33AM	Facebook co-founder Chris Hughes on U.S. industrial & tariff policies, AI data center investment (CNBC TV)
Nov-09-25 09:16AM	Leaked Documents Unveil Meta's $16 Billion Revenue Projection From Scam Ads (Benzinga)
Aug-02-25 04:39PM	Meta Just Paid $250M To Lure This 24-year-old AI Whiz Kid: A Strategic Move Or A Power Play? (Benzinga)
Jul-04-25 07:27PM	Zuck Bucks Are Back -- And This Time They're Fueling Meta's AI Comeback (GuruFocus.com)
05:46PM	WhatsApp Business Just Got Smarter -- Voice Calls and AI Recommendations Are Here (GuruFocus.com)
03:35PM	Google begins productive settlement talks with Trump lawyers, Atlantic says (TipRanks)
09:45AM	Meta upgraded, PNC Financial downgraded: Wall Streets top analyst calls (TipRanks)
07:00AM	The first big winners in the race to create AI superintelligence: the humans getting multi-million dollar pay packages (Fortune)
Jul-03-25 05:41PM	Meta's Momentum Hits a CapEx Hurdle (GuruFocus.com)
03:51PM	Who Won and Lost in Trumps Tax Bill (Bloomberg)
02:54PM	Loading…
02:54PM	Meta Offers to Buy Stake in Venture Funds Started by AI Hires Nat Friedman and Daniel Gross (The Wall Street Journal)
01:43PM	5 tech stock picks for the second half of 2025: Dan Ives (Yahoo Finance Video)
11:33AM	3 Chip Stocks to Buyand 1 to Avoidas Semiconductors Soar (Barrons.com)
11:12AM	Meta Stock Gets Upgrade To Hold From One Of Last Bearish Analysts On Wall Street (Investor's Business Daily)
10:50AM	Meta, FedEx, Oracle: Trending Tickers (Yahoo Finance Video)
10:25AM	Nvidia briefly on track to become world's most valuable company ever (Reuters)
09:41AM	Meta upgraded, PNC Financial downgraded: Wall Street's top analyst calls (The Fly)
07:27AM	Meta Platforms upgraded but Needham warns of capital waste and rising risks (Investing.com)
02:30AM	Investors in Virtual Farming Are Raking In Real Money (Barrons.com)
02:15AM	Former OpenAI Board Member Questions Zuckerberg AI Hiring Spree (Bloomberg)
Jul-02-25 05:27PM	Meta (META) Hires More OpenAI Talent as It Ramps Up AI Research (GuruFocus.com)
05:25PM	Meta (META) Price Target Raised to $740 at Baird on Messaging Monetization Push (GuruFocus.com)
04:07PM	Microsoft, Meta And 3 IPOs Lead This Barrage Of Breakout Stocks To Watch (Investor's Business Daily)
11:03AM	Meta Stock Gets Price-Target Hike From Analyst. Why AI Could Give WhatsApp A Boost. (Investor's Business Daily)
10:05AM	Paramount Settles Trumps 60 Minutes Suit for $16 Million (Bloomberg)
09:47AM	Loading…
09:47AM	Apple, Alphabet and Tesla are Holding the S&P 500 Rally Back (Bloomberg)
07:23AM	Nvidia reclaimed market value pole position in June (Reuters)
06:40AM	Trumps Feuds With Musk, Powell Are Not Stock Market Movers. This Is. (Barrons.com)
06:30AM	Meta vs. Nvidia: How to play Mag 7 in the second half of 2025 (Yahoo Finance Video)
06:00AM	Apple and Meta are proving it: AI is going corporate (Yahoo Finance)
Jul-01-25 04:05PM	Meta to Announce Second Quarter 2025 Results (PR Newswire)
03:37PM	Surge AI Eyes $15 Billion Valuation in First Fundraise (GuruFocus.com)
03:32PM	Meta Unifies Ads, Debuts Business AI on WhatsApp (GuruFocus.com)
02:58PM	X Will Deploy AI to Write Community Notes, Expand Fact-Checking (Bloomberg)
02:23PM	Senate Clears the Way for State AI Regulation. Meta, Amazon, and Alphabet Stock Fall. (Barrons.com)
01:00PM	How Meta's AI talent 'free agency' could reshape the tech race (Yahoo Finance Video)
12:36PM	Trumps Tax Bill Passes US Senate as Republicans Notch Major Win (Bloomberg)
11:39AM	BofA highlights Metas early AI gains and revenue momentum, reiterates Buy rating (Investing.com)
10:42AM	Meta Stock Looks to Build on Record High. A New AI Unit Could Hold the Key. (Barrons.com)
10:15AM	Netflixs Lofty Valuation Has Even Bullish Investors Nervous (Bloomberg)
08:13AM	Meta Shares Climb to Record High After Unveiling Superintelligence Labs (GuruFocus.com)
07:08AM	Stocks Rally as Robots Replace Humans. Why AI Job Losses Are Coming Fast. (Barrons.com)
Jun-30-25 07:36PM	OpenAI's Brain Gain for Meta Platforms Continues (GuruFocus.com)
06:33PM	Inside Meta's Superintelligence Push (GuruFocus.com)
04:55PM	Apple Weighs Using Anthropic or OpenAI to Power Siri in Major Reversal (Bloomberg)
04:35PM	Meta Stock Returns To Record High Amid 'Superintelligence' Push, OpenAI Talent Battle (Investor's Business Daily)
02:39PM	Zuckerberg Debuts Meta Superintelligence Group, More Hires (Bloomberg)
01:54PM	Meta forms AI superintelligence lab headed by Scale AIs Wang (Investing.com)
01:53PM	Trump Forces Canada's Hand -- Digital Tax Killed to Save $440B Trade Lifeline (GuruFocus.com)
10:50AM	Stocks to Watch: Meta, Tesla, Wells Fargo, Home Depot (The Wall Street Journal)
09:44AM	Tech Industry Cheers Canada's Withdrawal of Digital Tax (The Wall Street Journal)
09:00AM	Microsoft claims AI diagnostic tool can outperform doctors (Financial Times)
08:38AM	Meta's Next Big AI Move Turns Heads (GuruFocus.com)
08:13AM	Chinese tech stocks soar in 2025 while US giants stall (Yahoo Finance Video)
08:05AM	Meta May Ditch Its Own AI Models After Llama 4 Stumbles (GuruFocus.com)
07:51AM	Trump Deals Poised to Fall Short of Sweeping Trade Reforms (Bloomberg)
06:46AM	Trump Tariffs and Inflation Could Rain on Stock Markets' Summer Surge. Here's Why and 5 More Things to Know Today. (Barrons.com)
05:54AM	Trade Latest: Canada Pulls Digital Tax to Revive Talks With Trump (Barrons.com)
05:30AM	FOMO-Driven Call Buying Soars as Traders Chase S&P 500s Furious Run (Bloomberg)
12:01AM	Dealmakers Hit $1.8 Trillion as They Get Used to Trade Chaos (Bloomberg)
Jun-28-25 06:00AM	The tech rally is about a lot more than Magnificent 7 right now (Yahoo Finance)
01:43AM	Meta Faces Billion-Dollar Threat: EU Warns of Daily Fines Starting June 2025 (GuruFocus.com)
Jun-27-25 10:08PM	Meta Mulls Swapping Out Llama (GuruFocus.com)
05:57PM	Trump Ends Canada Trade Talks in Retaliation Over Digital Tax (Bloomberg)
04:00PM	Nvidia Stock Keeps Rocking Record Highs. Here's Why. (Investor's Business Daily)
02:42PM	Apple and Meta Could Face Daily EU Fines Starting Next Week (Barrons.com)
01:44PM	Alphabet Stock Is Having a Bad Year. How AI Can Make or Break the Google Parent. (Barrons.com)
12:54PM	The biggest AI companies you should know (Yahoo Finance)
12:05PM	Piper makes Meta its top large-cap pick, lifts price view on AI-driven ad gains (Investing.com)
06:30AM	After Reclaiming Worlds Most Valuable Company Crown, Nvidia Gilds the Tiara (The Daily Upside)

Proshares S&P 500 Dynamic Buffer ETF seeks investment results, before fees and expenses, that track the performance of the S&P 500 Daily Dynamic Buffer Index. The index measures the performance of this Dynamic Buffer Strategy based on the S&P 500 Index using a long position in the S&P 500 Index along with three different S&P 500 Index options that have one day to expiration. Under normal circumstances, the fund will invest at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

open in screener | open in yahoo | open in marketwatch | open in google

PLTR

Palantir Technologies Inc

ABCL

AbCellera Biologics Inc

FB

ProShares S&P 500 Dynamic Buffer ETF

Upgrade your FINVIZ experience